Aim project: The aim of the project is to develop and test a personalised intervention to improve medication adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose- and/or blood pressure lowering drugs.
Medication non-adherence is a prevalent health problem in people with type 2 diabetes mellitus. Multiple interventions have previously been developed to enhance medication adherence, but often moderate effects have been reported. An explanation for these moderate effects can be that interventions are not tailored to the needs and preferences of individual patients.
Therefore, the aim of this study is to develop and test a personalised intervention to improve medication adherence in people with T2DM, who are non-adherent to oral blood glucose and/or blood pressure lowering drugs. This will be tested in a parallel-group randomised controlled trial that will be conducted in 40-50 (community) pharmacies and adjoining practices in the Netherlands and the United Kingdom. A total of 300 participants will be included, 150 participants in the Netherlands and 150 participants in the UK, and the follow-up period of the trial will be six months.
Role of research group in this project: Petra Elders and Femke Rutters are part of the coordinating team of INTENSE and are involved in the supervision of the PhD student.Click to read more (external website)